Skip to content

Bandhatva Chikitsa

Effect of lasun tail uttar basti in female infertility

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/028074
Enrollment
60
Registered
2020-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: lasun tail uttar basti: 5 ml of drug for 7 days in one cycle after cessation of menstruation Control Intervention1: Shatpuspa tail uttar basti: satpuspa tail uttar basti 5 ml for 7 days

Sponsors

Government PG Ayurveda College and Hospital varanasi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All cases of primary and secondary infertility. 2. Age group between 20-40 year of age. 3. Male counterpart should be normal. 4. At least one fallopian tube must be patent.

Exclusion criteria

Exclusion criteria: 1. Age less than 20 years. 2. Age more than 40 years. 3. Patient suffering from pelvic pathology, including fibroid, cervical polyp, malignancy endometrial tuberculosis etc. 4. Congenital anomalies. 5.Patient suffering from severe infection or chronic systemic disease. 6. Bilateral tube blockage. 7. Infertility due to peritoneal factors. 8. Male counterpart is not normal.

Design outcomes

Primary

MeasureTime frame
to cure anovulatory cycle. to increase endometrial thickning.Timepoint: three to six months.

Secondary

MeasureTime frame
relief in associated symptoms.Timepoint: three to six months.

Countries

India

Contacts

Public ContactSadhna Verma

Government P.G. Ayurveda College and Hospital Varanasi

shashi.aymc@gmail.com9451680560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026